Since 1999, Clodoveo Ferri investigated the pathogenetic role of parvovirus B19 and cytomegalovirus (CMV) in systemic sclerosis (scleroderma): a significantly higher prevalence of parvovirus B19 infection was firstly demonstrated in both bone marrow and skin of scleroderma patients compared to controls.
A significantly higher prevalence of parvovirus B19 infection was originally demonstrated in both bone marrow and skin of scleroderma patients compared to controls. Since 1999, Ferri investigated the pathogenetic role of parvovirus B19 and cytomegalovirus (CMV) in systemic sclerosis (scleroderma).
Since 1999, Ferri investigated the pathogenetic role of parvovirus B19 and cytomegalovirus (CMV) in systemic sclerosis (scleroderma). A significantly higher prevalence of parvovirus B19 infection was originally demonstrated in both bone marrow and skin of scleroderma patients compared to controls.
Since 1999, Ferri investigated the pathogenetic role of parvovirus B19 and cytomegalovirus (CMV) in systemic sclerosis (scleroderma). A significantly higher prevalence of parvovirus B19 infection was originally demonstrated in both bone marrow and skin of scleroderma patients compared to controls.